Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,303Revenue (TTM) $M196Net Margin (%)42.7Altman Z-Score7.8
Enterprise Value $M1,229EPS (TTM) $1.6Operating Margin %23.3Piotroski F-Score6
P/E(ttm)16.6Beneish M-Score-1.5Pre-tax Margin (%)21.3Higher ROA y-yY
Price/Book7.410-y EBITDA Growth Rate %--Quick Ratio1.7Cash flow > EarningsN
Price/Sales6.85-y EBITDA Growth Rate %--Current Ratio1.9Lower Leverage y-yY
Price/Free Cash Flow22.5y-y EBITDA Growth Rate %152ROA % (ttm)39.8Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)65.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M50.1ROIC % (ttm)122Gross Margin Increase y-yY

Gurus Latest Trades with SUPN

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

SUPN is held by these investors:



SUPN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PATRICK GREGORY SVP, CFO 2016-09-16Sell2,000$251.2view
PATRICK GREGORY SVP, CFO 2016-07-14Sell3,395$2215view
Bhatt Padmanabh P.Sr. VP of IP, CSO 2016-04-11Sell30,762$16.4953.43view
Bhatt Padmanabh P.Sr. VP of IP, CSO 2015-12-09Sell14,238$14.969.8view
BARRETT M JAMESDirector 2015-12-08Sell212,970$14.5673.76view
BARRETT M JAMESDirector 2015-11-25Sell16,179$16.3554.74view
BARRETT M JAMESDirector 2015-11-18Sell93,000$16.6152.32view
BARRETT M JAMESDirector 2015-11-16Sell119,650$16.2455.79view
Bhatt Padmanabh P.Sr. VP of IP, CSO 2015-11-04Sell5,000$19.927.14view
Schwabe Stefan K.F.Executive Vice President R&D 2015-07-28Sell2,350$21.219.34view

Quarterly/Annual Reports about SUPN:

News about SUPN:

Articles On GuruFocus.com
Robert Bruce new Buys Feb 16 2015 
Third Quarter Was Robert Bruce's Busiest in 2014 Nov 21 2014 
Supernus Pharmaceuticals Reports Insider Buys Mar 26 2013 

More From Other Websites
Will Mylan, Glaukos, Supernus Live Up To Q4 Growth Views Next Week? Feb 24 2017
SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 15 2017
Supernus to Host Fourth Quarter and Full Year 2016 Earnings Conference Call Feb 13 2017
SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Feb 10 2017
Supernus Announces Issuance of Eighth U.S. Patent Protecting Trokendi XR® Feb 08 2017
Supernus Announces Issuance of Seventh U.S. Patent Protecting Trokendi XR® Jan 30 2017
SUPERNUS PHARMACEUTICALS INC Financials Jan 26 2017
Greater Washington's fastest-growing company forced to lower earnings, income for two years Jan 24 2017
Company News for January 24, 2017 Jan 24 2017
SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jan 23 2017
Supernus Pharmaceuticals, Inc. – Value Analysis (NASDAQ:SUPN) : January 23, 2017 Jan 23 2017
Supernus Files Form 10-Q for Third Quarter 2016 and Is Now Current with All Financial Filings Jan 23 2017
SUPERNUS PHARMACEUTICALS INC Files SEC form 10-Q/A, Quarterly Report Jan 23 2017
Supernus misses 3Q revenue forecasts Jan 20 2017
Supernus misses 3Q revenue forecasts Jan 20 2017
SUPERNUS PHARMACEUTICALS INC Files SEC form 10-Q/A, Quarterly Report Jan 20 2017
Supernus Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SUPN-US :... Jan 20 2017
Q4 Earnings Preview: Stocks Expecting 50% Or Higher Growth Jan 15 2017
SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 06 2017
Supernus to Present at the 2017 J.P. Morgan Healthcare Conference Jan 03 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)